Intel Corp. Publishes Whitepaper on AI to Cure Deadly Diseases

Intel Corporation recently published a whitepaper titled 'Optimizing Empathetic A.I. to Cure Deadly Diseases' which highlights the exemplary use of artificial intelligence analytic tools in targeting different variants of all viruses. The whitepaper is published in collaboration with Enzolytics inc., a drug development company that commercializes proprietary proteins for treating infectious diseases.

AI evolving future of healthcare from reactive to anticipatory

Biologist Leroy Hood gives an example of P4 Medicine while speaking of artificial intelligence and the future of healthcare. This includes-



Participatory- A crucial aspect wherein physicians are convinced for adopting newer technologies and offering digital experience through medicine. It involves educating patients regarding opportunities and challenges of technology, while also revolutionizing the mindset of a community.

Personalized- The second P targets personalization since every anatomy is genetically unique. This approach will give freedom to individuals when they move from healthier side to diseases.

Preventive- The medicine and healthcare industry that focuses largely on the future, and not just the present.

Predictive- Individual’s genetic makeup predicting diseases they can be at risk for.

Intel’s AI to deliver P4 Medicine model

The whitepaper published by Intel gives an insight into the use of artificial intelligence for the P4 medicine model. Intel has been making breakthrough advances in AI applications, outsourcing the tasks for healthcare, as well as decisions for rationalizing machines so as to free the time of healthcare professionals.
 
Artificial Intelligence can be used extensively in healthcare through solution architects such as being programmed to be prognostic, designed to be anticipatory, learning to be adaptive, and thriving on participatory acts.